Cell MedX (OTCMKTS:CMXC) Share Price Passes Below 50 Day Moving Average – Time to Sell?
by Tristan Rich · The Markets DailyCell MedX Corp. (OTCMKTS:CMXC – Get Free Report) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.26 and traded as low as $0.2470. Cell MedX shares last traded at $0.2470, with a volume of 150 shares.
Cell MedX Stock Performance
The stock has a 50 day moving average of $0.26 and a 200-day moving average of $0.30.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Recommended Stories
- Five stocks we like better than Cell MedX
- Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike